Tara Masterson
Impact in
- Hematology top 2%
- Multiple Myeloma Research and Treatments
- Oncology top 10%
- Peptidase Inhibition and Analysis
- CAR-T cell therapy research
Papers in
- Hematology 35
- Multiple Myeloma Research and Treatments 35
- Oncology 23
- Peptidase Inhibition and Analysis 12
- HER2/EGFR in Cancer Research 7
- Cancer Treatment and Pharmacology 4
- CAR-T cell therapy research 4
- Co-authors
- María‐Victoria Mateos (17 shared papers)Ajai Chari (18 shared papers)Philippe Moreau (13 shared papers)Thomas Renaud (21 shared papers)Niels W.C.J. van de Donk (14 shared papers)Jaszianne Tolbert (20 shared papers)Christoph Heuck (23 shared papers)Brandi Hilder (19 shared papers)
- Journals
- Blood (11 papers)Journal of Clinical Oncology (7 papers)Blood Cancer Journal (2 papers)HemaSphere (2 papers)Clinical Lymphoma Myeloma & Leukemia (10 papers)
- Partner nations
- United StatesSpainNetherlands
In The Last Decade
Tara Masterson
39 papers receiving 675 citations
Tara Masterson's Hit Papers
Peers
Comparison fields: 5 of 53
- Hematology 426
- Oncology 289
- Genetics 90
- Radiology, Nuclear Medicine and Imaging 155
- Immunology 134
Countries citing papers authored by Tara Masterson
This map shows the geographic impact of Tara Masterson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tara Masterson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tara Masterson more than expected).
Fields of papers citing papers by Tara Masterson
This network shows the impact of papers produced by Tara Masterson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tara Masterson. The network helps show where Tara Masterson may publish in the future.
Co-authors
The 25 scholars most cited alongside Tara Masterson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 81 | |
| 2 | 2023 | 64 | |
| 3 | GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review Hit paper breakdown → | 2024 | 62 |
| 4 | 2015 | 51 | |
| 5 | 2015 | 48 | |
| 6 | 2018 | 34 | |
| 7 | 2023 | 32 | |
| 8 | 2023 | 31 | |
| 9 | 2020 | 25 | |
| 10 | 2017 | 24 | |
| 11 | 2014 | 24 | |
| 12 | 2024 | 22 | |
| 13 | 2016 | 21 | |
| 14 | 2020 | 20 | |
| 15 | 2013 | 17 | |
| 16 | 2023 | 16 | |
| 17 | 2021 | 15 | |
| 18 | 2016 | 13 | |
| 19 | 2023 | 12 | |
| 20 | 2015 | 11 |
About Tara Masterson
Tara Masterson is a scholar working on Hematology, Oncology, Radiology, Nuclear Medicine and Imaging, Molecular Biology and Genetics, having authored 44 papers that have together received 696 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (35 papers), Monoclonal and Polyclonal Antibodies Research (21 papers), Peptidase Inhibition and Analysis (12 papers), HER2/EGFR in Cancer Research (7 papers), Chronic Lymphocytic Leukemia Research (6 papers), Cancer Treatment and Pharmacology (4 papers), CAR-T cell therapy research (4 papers) and Protein Degradation and Inhibitors (3 papers). The work is most often cited by research in Hematology (426 citations), Oncology (289 citations), Genetics (90 citations), Radiology, Nuclear Medicine and Imaging (155 citations) and Immunology (134 citations). Tara Masterson has collaborated with scholars based in United States, Spain and Netherlands. Frequent co-authors include María‐Victoria Mateos, Ajai Chari, Philippe Moreau, Thomas Renaud, Niels W.C.J. van de Donk, Jaszianne Tolbert, Christoph Heuck, Brandi Hilder, Xiang Qin and Jesús F. San Miguel. Their work appears in journals such as Blood, Journal of Clinical Oncology, Blood Cancer Journal, HemaSphere and Clinical Lymphoma Myeloma & Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.